Kyobu geka. The Japanese journal of thoracic surgery最新文献_第7页

[Bronchoscopic Lung Volume Reduction for Severe Emphysema]. [支气管镜下肺减容治疗严重肺气肿]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Takuma Nakano, Hirotsugu Notsuda, Ken Onodera, Tatsuaki Watanabe, Takashi Hirama, Yoshinori Okada

引用次数: 0

[Distal Stent Graft-induced New Entry on the Lesser Curvature of Distal Aortic Arch:Report of a Case]. [远端支架移植诱导主动脉弓远端小曲度新入路1例]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Toshifumi Saga, Masataka Koga, Shoichiro Izuka, Hiroyuki Miyagawa

引用次数: 0

[Anterolateral Partial Sternotomy as an Effective Approach for Open Repair After Debranching Thoracic Endovascular Aortic Repair in Aortic Arch Aneurysm]. 【前外侧部分胸骨切开术作为主动脉弓动脉瘤去分支胸血管内修复术后开放修复的有效方法】。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Mitsuru Sato, Takaaki Hayashi, Satoshi Taniguchi, Tomoyuki Goto

引用次数: 0

[Surgery for Cardiac Rhabdomyosarcoma in Jehovah's Witnesses:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Hideo Tsunemoto, Yoshinori Otsu, Keisuke Senda

引用次数: 0

[Surgical Treatment of Emphysema]. 肺气肿的外科治疗。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Chihiro Konoeda

引用次数: 0

[Therapeutic Experience with Three-port Thoracoscopic Lung Volume Reduction Surgery for Emphysema]. 【三孔胸腔镜肺减容术治疗肺气肿体会】。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Souichiro Suzuki, Sakashi Fujimori, Takahiro Karasaki, Shinichiro Kikunaga, Yosuke Hamada, Shusei Mihara

引用次数: 0

[Volume Reduction Surgery for Advanced Emphysema is Still Worthwhile to Be Considered]. [晚期肺气肿的减容手术仍值得考虑]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Tadasu Kohno

引用次数: 0

[Lung Volume Reduction for Chronic Obstructive Pulmonary Disease]. [慢性阻塞性肺疾病肺容量减少]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Yuriko Terada, Hirotaka Yuki, Satoshi Nishikawa, Takashi Wada, Daisuke Saito, Seiichi Kakegawa, Isao Matsumoto

{"title":"[Lung Volume Reduction for Chronic Obstructive Pulmonary Disease].","authors":"Yuriko Terada, Hirotaka Yuki, Satoshi Nishikawa, Takashi Wada, Daisuke Saito, Seiichi Kakegawa, Isao Matsumoto","doi":"","DOIUrl":"","url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) is increasing with population aging and currently ranks as the third leading cause of death worldwide, accounting for approximately three million deaths annually. COPD is characterized by irreversible airflow obstruction, mainly caused by reduced lung elastic recoil due to peripheral airway lesions and emphysema. This condition results in lung hyperinflation, causing dyspnea, reduced exercise capacity, decreased physical activity, and an increased risk of heart failure. For patients with severe COPD unresponsive to medical therapies, surgical interventions, such as lung volume reduction surgery (LVRS), bronchoscopic lung volume reduction (BLVR), or lung transplantation, are considered. LVRS improves respiratory function by surgically removing hyperinflated lung tissue;however, due to its invasiveness and complication risks, fewer than 20 cases are performed annually in Japan. In contrast, BLVR, particularly bronchoscopic valve placement, is less invasive and has demonstrated effectiveness, especially in patients without collateral ventilation, and was approved for insurance coverage in Japan in 2023. Recent trials indicate BLVR significantly improves respiratory function and quality of life, though pneumothorax remains a notable complication. Appropriate patient selection based on clinical features, imaging findings, and pulmonary function evaluation is crucial, emphasizing individualized therapeutic strategies for COPD management.","PeriodicalId":17841,"journal":{"name":"Kyobu geka. The Japanese journal of thoracic surgery","volume":"78 7","pages":"515-521"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Early and Long-term Results of Lung Volume Reduction Surgery for Severe Chronic Obstructive Pulmonary Disease Patient with Target Area Not Restricted in Upper Lobe]. [靶区不限于上肺叶的重型慢性阻塞性肺疾病患者肺减容手术的早期和远期效果]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Kouji Chihara, Masanao Nakai, Hisashi Sahara, Shigeki Tamari

{"title":"[Early and Long-term Results of Lung Volume Reduction Surgery for Severe Chronic Obstructive Pulmonary Disease Patient with Target Area Not Restricted in Upper Lobe].","authors":"Kouji Chihara, Masanao Nakai, Hisashi Sahara, Shigeki Tamari","doi":"","DOIUrl":"","url":null,"abstract":"The basic patient selection criteria in lung volume reduction surgery (LVRS) is that the target area (TA) is located in the upper lobe since National Emphysema Treatment Trial (NETT). TA could be described as \"airoma\" (AO) with excess residual volume and poor perfusion, which compresses the adjacent lung and heart during expiration and causes dyspnea during walking. After Cooper's landmark report, we defined AO not only by functional static images such as high resolution computed tomography(HRCT) and perfusion scintigrams but also dynamic image of magnetic resonance imaging( MRI)during ventilation, and selected 36 patients with a mean age of 69 years, body mass index (BMI) of 18 kg/m2, modified Medical Research Council( mMRC) of 2.7, PaO2 of 68 mmHg, PaCO2 of 44 mmHg, forced expiratory volume in on second( FEV1)% of 29, % residual volume( RV) of 255, 6-min walk of 285 m, and VO2 max of 12.5 ml/kg/min from October 1995 to October 2015. AO was located in the upper lobe in 19 patients, in the lower lobe in 13 patients, and in the middle lobe or bi-lobes in 4 patients. Reduction of AO was performed by median sternotomy or video-assisted thoracic surgery (VATS). There was zero 90-day operative mortality and zero in-hospital mortality. Thirty-three of 36 patients were satisfied with decrease in dyspnea during walking, and three disappointed. The median follow-up for all patients was 4.5 years. The 1, 3, and 5-year survival rates in the upper lobe group were 100%, 94%, and 49%, respectively, compared with 92%, 77%, and 54%, respectively, in the lower lobe group. There was no difference in survival between the two groups. We believe that selected patients with lower lobe AO are candidates for LVRS, as well as upper lobe AO.","PeriodicalId":17841,"journal":{"name":"Kyobu geka. The Japanese journal of thoracic surgery","volume":"78 7","pages":"522-529"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Lung Volume Reduction Surgery in the Bronchoscopic Lung Volume Reduction Era:Reassessment of Indications and Strategies]. [支气管镜肺减容时代的肺减容手术：适应症和策略的重新评估]。

Kyobu geka. The Japanese journal of thoracic surgery Pub Date : 2025-07-01

Shin Tanaka, Yasuaki Tomioka, Haruchika Yamamoto, Hidejiro Torigoe, Kazuhiko Shien, Ken Suzawa, Kentaroh Miyoshi, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka

引用次数: 0